A detailed history of Beaumont Financial Advisors, LLC transactions in Revolution Medicines, Inc. stock. As of the latest transaction made, Beaumont Financial Advisors, LLC holds 10,520 shares of RVMD stock, worth $712,730. This represents 0.06% of its overall portfolio holdings.

Number of Shares
10,520
Previous 10,520 -0.0%
Holding current value
$712,730
Previous $491,000 45.01%
% of portfolio
0.06%
Previous 0.04%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 23, 2025

SELL
$34.7 - $46.7 $111,178 - $149,626
-3,204 Reduced 23.35%
10,520 $491,000
Q1 2025

May 12, 2025

SELL
$35.36 - $44.42 $495 - $621
-14 Reduced 0.1%
13,724 $485,000
Q4 2024

Jan 17, 2025

SELL
$42.97 - $60.6 $50,962 - $71,871
-1,186 Reduced 7.95%
13,738 $600,000
Q4 2023

Jan 31, 2024

BUY
$18.35 - $34.12 $273,855 - $509,206
14,924 New
14,924 $428,000

Others Institutions Holding RVMD

About Revolution Medicines, Inc.


  • Ticker RVMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,697,600
  • Market Cap $5.94B
  • Description
  • Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also d...
More about RVMD
Track This Portfolio

Track Beaumont Financial Advisors, LLC Portfolio

Follow Beaumont Financial Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Beaumont Financial Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Beaumont Financial Advisors, LLC with notifications on news.